Loading...
Not a good buy right now. ORGN is a sub-$0.20 microcap in a clear downtrend (bearish moving-average stack) with deteriorating Q3’25 fundamentals and no proprietary buy signals today. With near-term pattern odds skewed slightly negative and support nearby but fragile, the risk/reward is unfavorable for an impatient buyer seeking immediate upside.
Price/Trend: Bearish trend structure with SMA_200 > SMA_20 > SMA_5, implying sustained downside momentum and weak intermediate/long-term trend. Momentum: RSI(6)=34 (weak/near-oversold but not a strong reversal trigger). MACD histogram is positive (0.00759) but positively contracting, suggesting any bounce is losing steam rather than accelerating into a new uptrend. Levels: Pivot=0.20 is immediate overhead resistance; failure to reclaim and hold above it keeps pressure on price. Key support S1=0.185 (then S2=0.176). Resistance levels: R1=0.215, R2=0.225. Near-term odds (pattern analogs): ~60% chance of -0.94% next day and -2.4% next week (slight bearish bias), with a modest +2.2% next month—i.e., not an attractive ‘buy now’ setup for fast upside.

and reclaims the 0.20 pivot.
suggests some market participants are positioned for upside.
and MACD momentum waning (positive but contracting).
and overall liquidity/volume is thin.
Latest quarter: 2025/Q3. Revenue: $4.657M, down -43.22% YoY (sharp contraction). Net income: -$16.382M, down -55.44% YoY (losses widening). EPS: -0.11, down -57.69% YoY. Gross margin: -57.53% (improved YoY but still deeply negative), indicating the core economics remain challenged despite some margin improvement.
No analyst rating/price target change data was provided, so a clear Wall Street consensus view cannot be confirmed from this dataset. Based on the available facts (weak Q3’25 growth and a persistent downtrend), the professional ‘pros’ case would rest mainly on optionality/turnaround and event-driven upside into earnings, while the ‘cons’ case is dominated by shrinking revenue, widening losses, and a technically bearish tape. Politicians/Influential figures: No recent congress trading data available; no politician buy/sell signal can be inferred. Intellectia Proprietary Trading Signals: No signal on given stock today.
